These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Jick S, Kaye JA, Li L, Jick H. Contraception; 2007 Jul; 76(1):4-7. PubMed ID: 17586129 [Abstract] [Full Text] [Related]
9. New Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra). Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit. J Fam Plann Reprod Health Care; 2004 Jan 04; 30(1):43-5. PubMed ID: 15006313 [Abstract] [Full Text] [Related]
10. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol. Brenner P. Contraception; 2006 Oct 04; 74(4):354; author reply 354-5. PubMed ID: 16982246 [No Abstract] [Full Text] [Related]
11. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress. Prescrire Int; 2004 Aug 04; 13(72):123-6. PubMed ID: 15532134 [Abstract] [Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive. Devineni D, Skee D, Vaccaro N, Massarella J, Janssens L, LaGuardia KD, Leung AT. J Clin Pharmacol; 2007 Apr 04; 47(4):497-509. PubMed ID: 17389559 [Abstract] [Full Text] [Related]
13. Advances in hormonal contraception. Gupta N. Adolesc Med Clin; 2006 Oct 04; 17(3):653-71; abstract xi. PubMed ID: 17030284 [Abstract] [Full Text] [Related]
14. A clinical study of transdermal contraceptive patch in Thai adolescence women. Piyasirisilp R, Taneepanichskul S. J Med Assoc Thai; 2008 Feb 04; 91(2):137-41. PubMed ID: 18389975 [Abstract] [Full Text] [Related]
16. The Evra (ethinyl estradiol/norelgestromin) contraceptive patch: estrogen exposure concerns. Wooltorton E. CMAJ; 2006 Jan 17; 174(2):164-5. PubMed ID: 16368722 [No Abstract] [Full Text] [Related]
17. A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol. Lippman JS, Shangold GA. Int J Fertil Womens Med; 1997 Jan 17; 42(4):230-9. PubMed ID: 9309456 [No Abstract] [Full Text] [Related]
18. Transdermal contraception methods: today's patches and new options on the horizon. Nelson AL. Expert Opin Pharmacother; 2015 Apr 17; 16(6):863-73. PubMed ID: 25800084 [Abstract] [Full Text] [Related]
19. [Transdermal contraception--a new beginning]. Sigridov I, Dikov I, Ivanov S. Akush Ginekol (Sofiia); 2004 Apr 17; 43 Suppl 1():19-27. PubMed ID: 15323313 [No Abstract] [Full Text] [Related]